Taigen Biopharmaceuticals Holdings Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Taigen Biopharmaceuticals Holdings Ltd

Watchlist Manager

Watchlist

Price: 8.47 TWD -0.59% Market Closed

Market Cap: NT$6B

T	Taigen Biopharmaceuticals Holdings Ltd TPEX:4157	TW
P	Pixon Technologies Corp TPEX:5248	TW
B	Basic Net SpA SWB:BCJ	IT
E	Ellaktor SA SWB:HLL	GR
K	Kodiak Copper Corp OTC:KDKCF	CA
	MACOM Technology Solutions Holdings Inc LSE:0A8Z	US

Profitability Summary

Taigen Biopharmaceuticals Holdings Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

94%

Strong 3Y Average Gross Margin

84%

Gross Margin is Increasing

91% > 94%

Exceptional Operating Margin

32%

Negative 3Y Average Operating Margin

-134%

Operating Margin is Increasing

-147% > 32%

Exceptional Net Margin

60%

Negative 3Y Average Net Margin

-46%

Net Margin is Increasing

-135% > 60%

Exceptional Free Cash Flow Margin

13%

Negative 3Y Average Free Cash Flow Margin

-16%

Free Cash Flow Margin is Increasing

Negative 3Y Average ROIC

-55%

ROIC is Increasing

-99% > 46%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.